RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells

Journal of Virology

Volumn 76, Issue 4, 2002, Pages 1914-1921

  Pai, Saparna ^a   O'Sullivan, Brendan J ^a   Cooper, Leanne ^a   Thomas, Ranjeny ^a   Khanna, Rajiv ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOREGULATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; BURKITT LYMPHOMA; CELL LINE, TRANSFORMED; CELL NUCLEUS; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VIRAL MATRIX PROTEINS;

EID: 0036146241     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.4.1914-1921.2002     Document Type: Article

References (40)

1. Localization of the major NF-κB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs
2. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3
3. The specificity of recognition of a cytotoxic T lymphocyte epitope
4. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1
5. Expression of the Epstein-Barr virus protein LMP1 mediates tumor regression in vivo
6. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr Virus infection in B lymphocytes
7. Role of the TRAF binding site and NF-κB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression
8. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100
9. Epstein-Barr virus latent membrane protein-1 (LMP1) C terminus activation region 2 (CTAR2) maps to the far C terminus and requires oligomerisation for NF-κB activation
10. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins
11. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule
12. Chimeric and mutated variants of LMP1. A helpful tool to analyze the structure-function relationship of a pseudoreceptor
13. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T-cell surveillance
14. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: Modulation of interferon-regulated gene expression by rel/nuclear factor κB
15. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma
16. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain
17. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB
18. How NF-κB is activated: The role of the IκB kinase (IKK) complex
19. Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases
20. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line
21. Localization of Epstein-Barr virus cytotoxic T-cell epitopes using recombinant vaccinia: Implications for vaccine development
22. Vaccine strategies against Epstein-Barr virus-associated diseases: Lessons from studies on cytotoxic T-cell mediated immune regulation
23. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: Coordinate up-regulation of peptide transporters and HLA-class I antigen expression
24. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: Influence of peptide conformation and TCR-peptide interaction
25. Epstein-Barr virus and its replication
26. LMP1 signal transduction differs substantially from TNF receptor I signaling in the molecular functions of TRADD and TRAF2
27. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade
28. Regulation of B-cell populations
29. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus
30. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
31. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants
32. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function
33. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates
34. Impaired assembly and transport of HLA-A and -B antigens in a mutant T × B cell hybrid
35. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier
36. Viral subversion of the immune system
37. Phosphorylation of human IKB-α on serines 32 and 36 controls IKB-α proteolysis and NF-κB activation in response to diverse stimuli
38. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses
39. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains
40. Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1